| Style | Citing Format |
|---|---|
| MLA | Mohammadi E, et al.. "Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications." Biomedicine and Pharmacotherapy, vol. 139, no. , 2021, pp. -. |
| APA | Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, Ahangarzadeh S, Beikmohammadi L, Shariati L, Hooshmandi S, Ataei B, Javanmard SH (2021). Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications. Biomedicine and Pharmacotherapy, 139(), -. |
| Chicago | Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, Ahangarzadeh S, Beikmohammadi L, et al.. "Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications." Biomedicine and Pharmacotherapy 139, no. (2021): -. |
| Harvard | Mohammadi E et al. (2021) 'Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications', Biomedicine and Pharmacotherapy, 139(), pp. -. |
| Vancouver | Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, Ahangarzadeh S, et al.. Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications. Biomedicine and Pharmacotherapy. 2021;139():-. |
| BibTex | @article{ author = {Mohammadi E and Shafiee F and Shahzamani K and Ranjbar MM and Alibakhshi A and Ahangarzadeh S and Beikmohammadi L and Shariati L and Hooshmandi S and Ataei B and Javanmard SH}, title = {Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications}, journal = {Biomedicine and Pharmacotherapy}, volume = {139}, number = {}, pages = {-}, year = {2021} } |
| RIS | TY - JOUR AU - Mohammadi E AU - Shafiee F AU - Shahzamani K AU - Ranjbar MM AU - Alibakhshi A AU - Ahangarzadeh S AU - Beikmohammadi L AU - Shariati L AU - Hooshmandi S AU - Ataei B AU - Javanmard SH TI - Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications JO - Biomedicine and Pharmacotherapy VL - 139 IS - SP - EP - PY - 2021 ER - |